Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002317622 | SCV000851229 | likely pathogenic | Inborn genetic diseases | 2016-11-25 | criteria provided, single submitter | clinical testing | The p.R198P variant (also known as c.593G>C), located in coding exon 1 of the PCDH19 gene, results from a G to C substitution at nucleotide position 593. The arginine at codon 198 is replaced by proline, an amino acid with dissimilar properties. This variant has been determined to be the result of a de novo mutation in one family with an isolated case of developmental delay and seizures. A different alteration located at the same position, p.R198L (also known as c.593G>T), was detected in a female individual with afebrile, focal, tonic, and tonic-clonic seizures (Higurashi N et al. Epilepsy Res., 2013 Sep;106:191-9). Based on our internal structural analysis, this arginine directly interacts with three adjacent amino acids, two of which coordinate Ca2+ binding, and this variant is anticipated to result in a decrease in structural stability. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |